Rcadia secures four patents for coronary CT decision support

Clint vanSonnenberg | | Health Imaging | Oncology Imaging
Rcadia Medical Imaging has been granted four U.S. patents for the company’s COR Analyzer System.

The U.S. Patent and Trademark Office approved the patents to protect COR Analyzer’s automated algorithmic analysis of coronary CT angiography and for the system’s detection of coronary artery pathology. In addition, the decision support system, which is aimed at emergency department triage of patients with coronary artery disease, gained coverage for its methods of results visualization and automatic assessment of study quality, Auburndale, Mass.-based Rcadia stated.

Clint vanSonnenberg

Related Content

High-intensity focused ultrasound could allow prostate cancer patients to avoid surgery
MRI-first approach could allow many to safely forego prostate biopsy
MRI guidance significantly reduces radiotherapy side effects compared to CT
Interventional procedure often as effective as surgery for difficult-to-treat liver cancer
AI tumor volume estimations could improve prostate cancer treatment strategies
MRI could be 'powerful tool' for guiding surgery decisions in patients with rectal cancer

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.